IBM’s (IBM) Confluent Deal Expected to Boost EBITDA and Free Cash Flow

IBM’s (IBM) Confluent Deal Expected to Boost EBITDA and Free Cash Flow

By Sheryar Siddiq
Publication Date: 2026-01-08 06:32:00

International Business Machines Corporation (NYSE:IBM) ranks among the best big data stocks to invest in.  On December 10, Bernstein SocGen Group maintained its Market Perform rating for International Business Machines Corporation (NYSE:IBM), with a $280 price target on the company’s shares. The rating follows IBM’s plans to buy all outstanding common shares of Confluent for $31 per share in cash, representing an enterprise value of roughly $11 billion.

JuliusKielaitis / Shutterstock.com

According to analyst Mark C. Newman, the deal is likely to boost IBM’s adjusted EBITDA during the first full year of completion.

The purchase is also expected to boost IBM’s free cash flow in the second year after completion.

On the other hand, S&P Global Ratings lowered IBM’s outlook to negative, projecting that the acquisition will keep the company’s leverage at roughly 2.5x in fiscal 2026. However, the firm anticipates IBM’s revenue to increase by 6% in fiscal…